| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/26/2004 | WO2004072250A2 Galacturonosyl transferases, nucleic acids encoding same and uses therefor |
| 08/26/2004 | WO2004072249A2 Polyvinylethers for delivery of polynucleotides to mammalian cells |
| 08/26/2004 | WO2004072247A2 Polymerase-based protocols for generating chimeric and combinatorial chimeric oligonucleotides |
| 08/26/2004 | WO2004072246A2 Polymerase-based protocols for the introduction of combinatorial deletions and insertions |
| 08/26/2004 | WO2004072245A2 Polymerase-based protocols for the introductions of deletions and insertions |
| 08/26/2004 | WO2004072244A2 Polymerase-based protocols for generating chimeric oligonucleotides |
| 08/26/2004 | WO2004072239A2 Novel polypeptides with antifungal activity |
| 08/26/2004 | WO2004072235A2 Cotton event mon 88913 and compositions and methods for detection thereof |
| 08/26/2004 | WO2004072233A2 Hiv-specific fusion proteins and therapeutic and diagnostic methods for use |
| 08/26/2004 | WO2004072229A2 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 08/26/2004 | WO2004072225A2 Transgenic fungi expressing bcl-2 and methods of using bcl-2 or portions thereof for improving biomass production, survival, longevity, stress resistance and pathogenicity of fungi |
| 08/26/2004 | WO2004072224A2 Detection of ochratoxin a producing fungi |
| 08/26/2004 | WO2004072221A2 Proteases |
| 08/26/2004 | WO2004072117A2 Antibodies to c-met for the treatment of cancers |
| 08/26/2004 | WO2004072116A2 ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-1β |
| 08/26/2004 | WO2004072115A2 Suppression of endogenous immunoglobulin expression in transgenic non-human animals expressing humanized or human antibodies |
| 08/26/2004 | WO2004072114A1 Method of diagnosing bovince blood coagulation factor xi deficiency |
| 08/26/2004 | WO2004072113A1 Method and compositions for boosting immune response |
| 08/26/2004 | WO2004072111A2 Novel therapeutic and diagnostic apoptotic inductors |
| 08/26/2004 | WO2004072109A1 Gene resistant to aphis gossypii |
| 08/26/2004 | WO2004072100A2 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | WO2004072098A2 Immunocompromised rodents as dual color tumor models |
| 08/26/2004 | WO2004071662A1 Improvements in and relating to the handling of dna |
| 08/26/2004 | WO2004071534A1 Preventives/remedies for kidney diseases |
| 08/26/2004 | WO2004071467A2 Production of very long chain polyunsaturated fatty acids in oilseed plants |
| 08/26/2004 | WO2004071462A2 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 08/26/2004 | WO2004071443A2 Methods and compositions for modulating stem cells |
| 08/26/2004 | WO2004071430A2 RNAi TARGETING OF VIRUSES |
| 08/26/2004 | WO2004071418A2 Compounds for the treatment of systemic lupus erythematosus |
| 08/26/2004 | WO2004071407A2 Antisense modulation of ptp1b expression |
| 08/26/2004 | WO2004071405A2 Lactate dehydrogenase: a target and reagent for diabetes therapy |
| 08/26/2004 | WO2004071272A2 Animal selected for lacking heparan sulfate 3-o-sulfotransferase-1 and uses thereof |
| 08/26/2004 | WO2004071269A2 Gene marker and composition for diagnosis and treatment of neurological disorders and diseases and use of the same |
| 08/26/2004 | WO2004071186A1 Animal model for inflammatory bowel disease |
| 08/26/2004 | WO2004071178A2 Annexin and p34 promoters and use in expression of transgenic genes in plants |
| 08/26/2004 | WO2004071177A2 Sialylation of glycoproteins in plants |
| 08/26/2004 | WO2004071168A2 Nucleic acids encoding anthelmintic agents and plants made therefrom |
| 08/26/2004 | WO2004061112A3 Method of identifying organisms having a mutated signal transduction pathway |
| 08/26/2004 | WO2004058980A3 Plants having modified growth characteristics and a method for making the same |
| 08/26/2004 | WO2004057002A3 Production of heterologous glycosylated proteins in bryophyte cells |
| 08/26/2004 | WO2004056991A3 Novel angiogenic molecular target and uses thereof |
| 08/26/2004 | WO2004046379A9 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used |
| 08/26/2004 | WO2004046359A3 Method of controlling gene expression in plants or plant cells |
| 08/26/2004 | WO2004046318A3 Improved clonal cell lines derived from bti-tn-5b1-4 |
| 08/26/2004 | WO2004044190A3 Zymogen-like protein c polypeptides |
| 08/26/2004 | WO2004044163A9 Methods for identifying risk of melanoma and treatments thereof |
| 08/26/2004 | WO2004044145A3 Compositions and methods for enhancing disease resistance in fish |
| 08/26/2004 | WO2004044141A8 Conjugated oligomeric compounds and their use in gene modulation |
| 08/26/2004 | WO2004041856A3 Crystal structures of bacterial inorganic pyrophosphatases |
| 08/26/2004 | WO2004039834A3 Recombinant protein variants |
| 08/26/2004 | WO2004035819A3 Oligonucleotide analogues for detecting and analyzing nucleic acids |
| 08/26/2004 | WO2004035787A3 Transplantable cell with immune modulator |
| 08/26/2004 | WO2004035755A3 Transporters and ion channels |
| 08/26/2004 | WO2004035735A3 A structured peptide scaffold for displaying turn libraries on phage |
| 08/26/2004 | WO2004035609A3 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions. |
| 08/26/2004 | WO2004033689A3 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
| 08/26/2004 | WO2004033660A3 Gene expression profiling from ffpe samples |
| 08/26/2004 | WO2004020594A3 Solanum bulbocastanum late blight resistance gene and use thereof |
| 08/26/2004 | WO2004018992A3 Method and composition for forming a protective coating on an assay substrate and substrate produced by the same |
| 08/26/2004 | WO2004018706A3 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 08/26/2004 | WO2004018684A3 T-cell epitopes in staphylococcal enterotoxin b |
| 08/26/2004 | WO2004016749A3 Antisense modulation of acyl-coa synthetase 1 expression |
| 08/26/2004 | WO2004015127A3 Anticodon-based libraries and molecules for the specific shotgun and/or direct targeting of, and/or interaction with cells, tissues, surfaces, materials, molecules, and energy fields |
| 08/26/2004 | WO2004013310A3 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 08/26/2004 | WO2004011615A3 USES OF CIRCADIAN GENE mPER2 |
| 08/26/2004 | WO2004009018A3 Antisense modulation of ptprm expression |
| 08/26/2004 | WO2004002431A3 Humanized anti-lymphotoyin beta receptor antibodies |
| 08/26/2004 | WO2004000207A3 Toxin-phage bacteriocide antibiotic and uses thereof |
| 08/26/2004 | WO2003106654A3 Xylanases, nucleic adics encoding them and methods for making and using them |
| 08/26/2004 | WO2003100017A3 Oligonucleotides having modified nucleoside units |
| 08/26/2004 | WO2003095655A3 Methods for increasing oil content in plants |
| 08/26/2004 | WO2003093441A3 A method of regulating gene expression |
| 08/26/2004 | WO2003093411A3 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 08/26/2004 | WO2003092627A3 High throughput screening assay for detecting a dna sequence |
| 08/26/2004 | WO2003092602A3 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/26/2004 | WO2003091399A3 Production and use of salt tolerant and culture density tolerant organisms |
| 08/26/2004 | WO2003087320A3 Antagonists of il-21 and modulation of il-21-mediated t cell responses |
| 08/26/2004 | WO2003077859A3 Method of inducing an enhanced immune response against hiv |
| 08/26/2004 | WO2003070911A3 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/26/2004 | WO2003055440A3 Compositions and methods for the treatement of immune related diseases |
| 08/26/2004 | WO2003052055A3 Egvii endoglucanase and nucleic acids encoding the same |
| 08/26/2004 | WO2003049525A3 Methods and materials for the production of organic products in cells of $i(candida) species |
| 08/26/2004 | WO2003044168A3 Facilitation of rna interference |
| 08/26/2004 | WO2003040388A3 Method for detecting bacteria associated with parodontitis and tooth decay |
| 08/26/2004 | WO2003035843A3 Screening system for modulators of her2 mediated transcription and her2 modulators identifed thereby |
| 08/26/2004 | WO2003035829A3 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 08/26/2004 | WO2002102320A3 Fce fusion proteins for treatment of allergy and asthma |
| 08/26/2004 | WO2002090562A3 Methods for the reduction of stutter in microsatellite amplification |
| 08/26/2004 | WO2002085302A3 Methods of treating intestinal inflammation |
| 08/26/2004 | WO2002079447A8 Avian lysozyme promoter |
| 08/26/2004 | WO2002044334A3 Recombinant rsv virus expression systems and vaccines |
| 08/26/2004 | WO2002030268A3 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 08/26/2004 | US20040168217 used to enhance tissue culture response, induce somatic embryogenesis, induce apomixis, increase transformation efficiency or increase recovery of regenerated plants; genetic engineering |
| 08/26/2004 | US20040168215 Plant gene expression system for processing, targeting and accumulating foreign proteins in transgenic seeds |
| 08/26/2004 | US20040168214 Process for increasing the yield in plants by expressing stably integrated recombinant polypeptides |
| 08/26/2004 | US20040168213 Nucleic acids encoding anthelmintic agents and plants made therefrom |
| 08/26/2004 | US20040168212 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 08/26/2004 | US20040168211 Regulation of quinolate phosphoribosyl transferase expression |
| 08/26/2004 | US20040168210 for drug screening anticancer/osteoporosis agents; animal models; genetic engineering |
| 08/26/2004 | US20040168208 can be used to treat and/or prevent organophosphate pesticide/nerve gas poisoning, cocaine intoxication, and succinylcholine-induced apnea; genetic engineering |